SCTR and renal carcinoma: Interestingly, the gene probes targeting FGF17, PRKCG, SSTR1, and SCTR predicted potential targeted agents for renal cancer metastasis and adjuvant immunotherapy, including 5224221, calmidazolium, and sulfasalazine.